Drug repositioning finds new uses for existing medicines, cutting development time and costs dramatically. AI accelerates this by identifying hidden drug-disease links and improving success rates. This approach offers quicker, safer options to tackle diseases with unmet medical needs, but the government's drug pricing system has become a barrier to development. Guest: Mamiya Hiroaki (Associate Professor, College of Pharmaceutical Sciences, Ritsumeikan University)